{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T18:15:54Z","timestamp":1778264154766,"version":"3.51.4"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0211721","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T18:37:26Z","timestamp":1551292646000},"page":"e0211721","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non\u2013muscle-invasive bladder cancer and with low and intermediate EORTC-risk score"],"prefix":"10.1371","volume":"14","author":[{"given":"Marie","family":"Simon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Olivier","family":"Bosset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Rouanne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Benhamou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camelia","family":"Radulescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Molini\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yann","family":"Neuzillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1250-0040","authenticated-orcid":true,"given":"Xavier","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Lebret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"J Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"ref2","unstructured":"Roupr\u00eat M, Neuzillet Y, Masson-Lecomte A, Colin P, Comp\u00e9rat E, Dubosq F, Hou\u00e9d\u00e9 N, Larr\u00e9 S, Pignot G, Puech P, Roumigui\u00e9 M, Xylinas E, M\u00e9jean A. CCAFU french national guidelines 2016\u20132018 on bladder cancer."},{"issue":"Suppl 4","key":"ref3","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.1016\/S1166-7087(10)70043-9","article-title":"Recommendations Onco-Urology 2010: Urothelial tumors","volume":"20","author":"C Pfister","year":"2010","journal-title":"Prog Urol"},{"key":"ref4","author":"M Babjuk","year":"2018"},{"key":"ref5","article-title":"Bladder cancer","author":"MA Kamat","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eururo.2009.06.028","article-title":"Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy","volume":"56","author":"BW Van Rhijn","year":"2009","journal-title":"Eur Urol"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ajcp\/aqw103","article-title":"A Review of Outcomes for Stage Ta Bladder Tumors","volume":"146","author":"RT Volmer","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"RJ Sylvester","year":"2006","journal-title":"Eur Urol"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"20.e1","DOI":"10.1016\/j.urolonc.2014.09.001","article-title":"Long-term follow-up of TaG1 non-muscle-invasive bladder cancer","volume":"33","author":"O Bosset","year":"2015","journal-title":"Urol Oncol"},{"key":"ref10","first-page":"201","article-title":"Long-term cancer-specific outcomes of TaG1 urothelial carcinoma of the bladder","volume":"65","author":"M Rieken","year":"2014","journal-title":"EurUrol"},{"key":"ref11","article-title":"Risk estimation of multiple recurrence and progression of non muscle invasive bladder carcinoma using new mathematical models","author":"S Luj\u00e1n","year":"2014","journal-title":"Actas Urol Esp"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1464-410x.2000.00547.x","article-title":"Long-term follow-up of noninvasive bladder tumours (stage Ta): recurrence and progression","volume":"85","author":"K Zieger","year":"2000","journal-title":"BJU International"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.eururo.2007.10.006","article-title":"Prognostic factors in patients with non\u2013muscle-invasive bladder cancer treated with bacillus Calmette-Guerin: multivariate analysis of data from four randomized CUETO trials","volume":"53","author":"J Fernandez-Gomez","year":"2008","journal-title":"Eur Urol"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.eururo.2006.03.022","article-title":"Should bladder biopsies be performed routinely after bacillus Calmette-Gu\u00e9rin treatment for high-risk superficial transitional cell cancer of the bladder?","volume":"50","author":"L Guy","year":"2006","journal-title":"Eur Urol"},{"key":"ref15","first-page":"399","article-title":"Pronostic value of ureteral location of upper tract urinary carcinoma","volume":"23","author":"C Le Goux","year":"2013","journal-title":"Progr\u00e8s en urologie"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1464-410X.2002.02880.x","article-title":"Does smoking status influence the prognosis of bladder cancer? A systematic review","volume":"90","author":"P Aveyard","year":"2002","journal-title":"BJU Int."},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"M Schemper","year":"1996","journal-title":"Control Clin Trials"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1200\/JCO.2013.49.5283","article-title":"Challenges of Guarantee-Time Bias","volume":"31","author":"Giobbie-Hurder Anita","journal-title":"Clin Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCOUTCOMES.110.957951","article-title":"Landmark Analysis at the 25-Year Landmark Point","volume":"4","author":"Urania Dafni","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2307\/2061224","article-title":"The impact of heterogeneity in individual frailty on the dynamics of mortality","volume":"16","author":"JW Vaupel","year":"1979","journal-title":"Demography"},{"key":"ref21","unstructured":"Gui-shuang Y, Chengcheng L. Statistical Analysis of Clustered Data using SAS\u00ae System."},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.urology.2007.08.014","article-title":"Economic impact of tumor markers in bladder cancer surveillance","volume":"71","author":"YM Hong","year":"2008","journal-title":"Urology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.urology.2016.07.063","article-title":"Long-term Bladder and Upper Urinary Tract Follow-up Recurrence and Progression Rates of G1-2 Non-muscle-invasive Urothelial Carcinoma of the Bladder","volume":"100","author":"T Golabesk","year":"2017","journal-title":"Urology"},{"issue":"16","key":"ref24","doi-asserted-by":"crossref","first-page":"e0522","DOI":"10.1097\/MD.0000000000010522","article-title":"Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors","volume":"97","author":"D Balan","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00345-007-0213-4","article-title":"Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target","volume":"25","author":"MA Knowles","year":"2007","journal-title":"World J Urol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1200\/JCO.2005.05.1771","article-title":"Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas","volume":"24","author":"S Hernandez","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.eururo.2010.05.043","article-title":"Molecular grade (FGFR3\/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancer","volume":"58","author":"BW Van Rhijn","year":"2010","journal-title":"Eur Urol"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2016.05.004","article-title":"Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma","volume":"30","author":"J Hedegaard","year":"2016","journal-title":"Cancer Cell"},{"issue":"7","key":"ref29","doi-asserted-by":"crossref","first-page":"e0158891","DOI":"10.1371\/journal.pone.0158891","article-title":"Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis","volume":"11","author":"Y Tian","year":"2016","journal-title":"PLoS ONE"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0211721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T10:47:43Z","timestamp":1589021263000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0211721"}},"subtitle":[],"editor":[{"given":"Francisco X.","family":"Real","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0211721","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,27]]}}}